Thus, it is possible that in COVID-19 subjects circulating CD8 T-cells exhibit the activated profile of purinergic ectoenzymes at the time of hospitalization (CD39high and CD73low) but this pattern returns to the basal or homeostatic levels (CD39low and CD73high) in recovered patients. The gene discussed is CD8A; the disease is COVID-19.